Literature DB >> 14687729

A biased Valpha24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease.

Thomas Démoulins1, Gabriel Gachelin, Daniel Bequet, Dominique Dormont.   

Abstract

As natural killer T (NKT) cells have been implicated in the regulation of multiple sclerosis (MS), we investigated expression of the Valpha24JalphaQ canonical rearrangement in MS patients during relapses. We observed major changes in the entire blood Valpha24(+) T-cell repertoire. Seven of the eight patients showed a marked decrease in Valpha24(+) transcript number and a decrease in the diversity of the Valpha24(+) T-cell repertoire, with the exception of a few expanded clones. These perturbations, exacerbated in patient MS (A), led to circulating NKT cell defects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14687729     DOI: 10.1016/j.imlet.2003.09.014

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

Review 1.  Invariant natural killer T cells and their ligands: focus on multiple sclerosis.

Authors:  Joan O'Keeffe; Maria Podbielska; Edward L Hogan
Journal:  Immunology       Date:  2015-06-25       Impact factor: 7.397

2.  The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.

Authors:  Maria Podbielska; Steven B Levery; Edward L Hogan
Journal:  Clin Lipidol       Date:  2011-04

3.  Natural killer T cells constitutively expressing the interleukin-2 receptor α chain early in life are primed to respond to lower antigenic stimulation.

Authors:  Mihoko Ladd; Ashish Sharma; Qing Huang; Adele Y Wang; Lixin Xu; Indira Genowati; Megan K Levings; Pascal M Lavoie
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

Review 4.  Presumed guilty: natural killer T cell defects and human disease.

Authors:  Stuart P Berzins; Mark J Smyth; Alan G Baxter
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

5.  T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired.

Authors:  Joan O'Keeffe; Carol M Gately; Timothy Counihan; Michael Hennessy; Teresa Leahy; Anthony P Moran; Edward L Hogan
Journal:  J Neurol Sci       Date:  2008-08-15       Impact factor: 3.181

6.  Polymorphisms in the CD1d promoter that regulate CD1d gene expression are associated with impaired NKT cell development.

Authors:  Zachary D Borg; Patrick J Benoit; Graham W J Lilley; Idil Aktan; Alan Chant; Victoria L DeVault; Mercedes Rincon; Jonathan E Boyson
Journal:  J Immunol       Date:  2013-12-04       Impact factor: 5.422

7.  Massively parallel interrogation and mining of natively paired human TCRαβ repertoires.

Authors:  Matthew J Spindler; Ayla L Nelson; Ellen K Wagner; Natasha Oppermans; John S Bridgeman; James M Heather; Adam S Adler; Michael A Asensio; Robert C Edgar; Yoong Wearn Lim; Everett H Meyer; Robert E Hawkins; Mark Cobbold; David S Johnson
Journal:  Nat Biotechnol       Date:  2020-03-16       Impact factor: 54.908

Review 8.  The Role of NKT Cells in Glioblastoma.

Authors:  Emily E S Brettschneider; Masaki Terabe
Journal:  Cells       Date:  2021-06-30       Impact factor: 6.600

Review 9.  New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration.

Authors:  Maria Podbielska; Joan O'Keeffe; Anna Pokryszko-Dragan
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

10.  Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients.

Authors:  Diana Ferraro; Sara De Biasi; Anna Maria Simone; Riccardo Orlandi; Milena Nasi; Francesca Vitetta; Marcello Pinti; Marco Fogliani; Stefano Meletti; Andrea Cossarizza; Patrizia Sola
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.